These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


364 related items for PubMed ID: 35428224

  • 1. Exploring socio-demographic, physical, psychological, and quality of life-related factors related with fear of cancer recurrence in stomach cancer survivors: a cross-sectional study.
    Shin J, Shin DW, Lee J, Hwang J, Lee JE, Cho B, Song YM.
    BMC Cancer; 2022 Apr 15; 22(1):414. PubMed ID: 35428224
    [Abstract] [Full Text] [Related]

  • 2. Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence.
    Fardell JE, Jones G, Smith AB, Lebel S, Thewes B, Costa D, Tiller K, Simard S, Feldstain A, Beattie S, McCallum M, Conquer Fear authorship groupPsycho-Oncology Co-operative Research Group, School of Psychology, University of Sydney, Sydney, New South Wales, Australia., Butow P.
    Psychooncology; 2018 Feb 15; 27(2):492-499. PubMed ID: 28755462
    [Abstract] [Full Text] [Related]

  • 3. Fear of Cancer Recurrence in peritoneal malignancy patients following treatment: a cross-sectional study.
    Taher R, Carr NJ, Vanderpuye N, Stanford S.
    J Cancer Surviv; 2023 Apr 15; 17(2):300-308. PubMed ID: 35900688
    [Abstract] [Full Text] [Related]

  • 4. Fear of cancer recurrence among cancer survivors in Singapore.
    Mahendran R, Liu J, Kuparasundram S, Simard S, Chan YH, Kua EH, Griva K.
    Singapore Med J; 2021 Jun 15; 62(6):305-310. PubMed ID: 31989183
    [Abstract] [Full Text] [Related]

  • 5. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.
    Smith A', Sharpe L, Thewes B, Turner J, Gilchrist J, Fardell JE, Girgis A, Tesson S, Descallar J, Bell ML, Beith J, Butow P, ConquerFear Authorship Group.
    Support Care Cancer; 2018 Dec 15; 26(12):4207-4216. PubMed ID: 29882025
    [Abstract] [Full Text] [Related]

  • 6. Measuring fear of cancer recurrence in survivors of childhood cancer: Development and preliminary validation of the Fear of Cancer Recurrence Inventory (FCRI)-Child and Parent versions.
    Tutelman PR, Chambers CT, Heathcote LC, Fernandez CV, Flanders A, Patton M, Schulte FSM, Guilcher GMT, Simard S, MacLeod J, Stern M.
    Psychooncology; 2022 Jun 15; 31(6):911-919. PubMed ID: 35018689
    [Abstract] [Full Text] [Related]

  • 7. Initial validation of the Danish version of the Fear of Cancer Recurrence Inventory (FCRI) in colorectal cancer patients.
    Hovdenak Jakobsen I, Jeppesen MM, Simard S, Thaysen HV, Laurberg S, Juul T.
    J Cancer Surviv; 2018 Dec 15; 12(6):723-732. PubMed ID: 30128857
    [Abstract] [Full Text] [Related]

  • 8. Psychometric Characteristics of the Fear of Cancer Recurrence Inventory-Severity Subscale Among Korean Cancer Survivors.
    Park SY.
    J Prev Med Public Health; 2024 Jul 15; 57(4):319-326. PubMed ID: 38853579
    [Abstract] [Full Text] [Related]

  • 9. Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors.
    Thewes B, Bell ML, Butow P.
    Psychooncology; 2013 Sep 15; 22(9):2059-63. PubMed ID: 23408595
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fear of cancer recurrence in Non- and Hodgkin lymphoma survivors during their first three years of survivorship among French patients.
    Walburg V, Rueter M, Lamy S, Compaci G, Lapeyre-Mestre M, Laurent G, Despas F.
    Psychol Health Med; 2019 Aug 15; 24(7):781-787. PubMed ID: 30714815
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Exploring characteristics, predictors, and consequences of fear of cancer recurrence among Asian-American breast cancer survivors.
    Ashing KT, Cho D, Lai L, Yeung S, Young L, Yeon C, Fong Y.
    Psychooncology; 2017 Dec 15; 26(12):2253-2260. PubMed ID: 27992680
    [Abstract] [Full Text] [Related]

  • 15. Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.
    Dieng M, Kasparian NA, Cust AE, Costa DSJ, Tran A, Butow PN, Menzies SW, Mann GJ, Morton RL.
    JAMA Dermatol; 2018 Jan 01; 154(1):52-59. PubMed ID: 29188268
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fear of cancer recurrence and its predictors and outcomes among cancer survivors: A descriptive correlational study.
    Rha SY, Park JS, Choi YY, Hong B, Lee J.
    Eur J Oncol Nurs; 2022 Jun 01; 58():102138. PubMed ID: 35490660
    [Abstract] [Full Text] [Related]

  • 18. Fear of cancer recurrence: a significant concern among partners of prostate cancer survivors.
    van de Wal M, Langenberg S, Gielissen M, Thewes B, van Oort I, Prins J.
    Psychooncology; 2017 Dec 01; 26(12):2079-2085. PubMed ID: 28317267
    [Abstract] [Full Text] [Related]

  • 19. The impact of fear of cancer recurrence on healthcare utilization among long-term breast cancer survivors recruited through ECOG-ACRIN trials.
    Vachon E, Krueger E, Champion VL, Haggstrom DA, Cella D, Cohee AA.
    Psychooncology; 2021 Mar 01; 30(3):279-286. PubMed ID: 33022832
    [Abstract] [Full Text] [Related]

  • 20. Fear of cancer recurrence in haematological cancer patients: exploring socio-demographic, psychological, existential and disease-related factors.
    Borreani C, Alfieri S, Farina L, Bianchi E, Corradini P.
    Support Care Cancer; 2020 Dec 01; 28(12):5973-5982. PubMed ID: 32285261
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.